Biomaterials-assisted exosomes therapy in osteoarthritis
Authors:
- 2 February 2022
- journal article
- review article
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (2) , 022001
Abstract
Due to the avascular characteristic of articular cartilage, its self-repair capacity is limited. When cartilage is damaged or forms osteoarthritis (OA), clinical treatment is necessary. However, conventional treatments, including joint replacement, microfracture, cell and drug therapies, have certain limits. Lately, the exosomes derived from mesenchymal stem cells (MSCs-EXO), which consist of complex transcription factors, proteins and targeting ligand components, have shown great therapeutic potentials. With recent advancements in various biomaterials to extend MSCs-EXO’s retention time and control the release properties in vivo , biomaterials-assisted exosomes therapy has been soon becoming a practically powerful tool in treating OA. This review analyzes the effects of MSCs-EXO on OA inflammation, metabolism, ageing and apoptosis, and introduces the combinational systems of MSCs-EXO with biomaterials to enhance the repair, anti-inflammatory, and homeostasis regulation functions. Moreover, different types of natural or synthetic biomaterials and their applications with MSCs-EXO were also described and discussed. And finally, we presage the future perspective in the development of biomaterial-assisted exosome therapies, as well as the potential to incorporate with other treatments to enhance their therapeutic effects in OA.Keywords
Funding Information
- National Key Research Program of China (2018YFC1105900)
- Sichuan Science and Technology Program (2021JDRC0040)
- National Natural Science Foundation of China (32071353)
- Higher Education Discipline Innovation Project (B16033)
This publication has 73 references indexed in Scilit:
- Degradable natural polymer hydrogels for articular cartilage tissue engineeringJournal of Chemical Technology & Biotechnology, 2012
- Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic ProteasomeInternational Journal of Proteomics, 2012
- Inflammation in osteoarthritisCurrent Opinion in Rheumatology, 2011
- Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular InjuryJournal of the American Society of Nephrology, 2009
- Remodelling of human osteoarthritic cartilage by FGF‐2, alone or combined with Sox9 via rAAV gene transferJournal of Cellular and Molecular Medicine, 2008
- Yet more evidence that osteoarthritis is not a cartilage diseaseAnnals of the Rheumatic Diseases, 2006
- Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffoldsBiomaterials, 2005
- Designing materials for biology and medicineNature, 2004
- Upregulation of enzymatic activity by interleukin-1 in osteoarthritisBiomedicine & Pharmacotherapy, 1997
- Comparison of an Antiinflammatory Dose of Ibuprofen, an Analgesic Dose of Ibuprofen, and Acetaminophen in the Treatment of Patients with Osteoarthritis of the KneeNew England Journal of Medicine, 1991